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Gene expression networks underlying retinoic acid–induced differentiation of
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To elucidate the molecular mechanism
of all-trans-retinoic acid (ATRA)–in-
duced differentiation of acute promyelo-
cytic leukemia (APL) cells, the gene
expression patterns in the APL cell line
NB4 before and after ATRA treatment
were analyzed using complementary
DNA array, suppression-subtractive hy-
bridization, and differential-display–
polymerase chain reaction. A total of
169 genes, including 8 novel ones, were
modulated by ATRA. The ATRA-induced
gene expression proﬁles were in high
accord with the differentiation and pro-
liferation status of the NB4 cells. The
time courses of their modulation were
interesting. Among the 100 up-regu-
lated genes, the induction of expression
occurred most frequently 12-48 hours
after ATRA treatment, while 59 of 69
down-regulated genes found their ex-
pression suppressed within 8 hours.
The transcriptional regulation of 8 induced
and 24 repressed genes was not blocked by
cycloheximide,whichsuggeststhatthese
genes may be direct targets of the ATRA
signaling pathway. A balanced functional
network seemed to emerge, and it formed
the foundation of decreased cellular pro-
liferation, maintenance of cell viability, in-
creased protein modulation, and promo-
tion of granulocytic maturation. Several
cytosolic signaling pathways, including
JAKs/STAT and MAPK, may also be impli-
cated in the symphony of differentiation.
(Blood. 2000;96:1496-1504)
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Introduction
Acute promyelocytic leukemia (APL) is an interesting model in the
study of human cancer because it is the ﬁrst human malignancy that
can be effectively treated with a cell differentiation inducer,
all-trans-retinoic acid (ATRA). During the last decade, it was
uncovered that the promyelocytic leukemia–retinoic acid re-
sponse-a (PML/RARA) fusion gene, which was generated as a
result of theAPL-speciﬁc chromosome translocation t(15;17)(q22;
q21) (translocation involving breaks at chromosome 15, long arm,
band 22, and chromosome 17, long arm, band 21), plays a central
role in leukemogenesis.1 On one hand, the creation of PML/RARA
disrupts the normal location of the PMLnuclear body or oncogenic
domains (PODs)2,3 and interferes with the function of PML for
growth inhibition and apoptosis regulation.4,5 On the other hand,
the RARA/RXR pathway, which is indispensable to the granulo-
cytic differentiation, was also damaged due to the sequestration of
RXR by heterodimerization with PML/RARA.6 Moreover, both
PML/RARA and RARA can interact with a large ubiquitous
nuclear corepressor (N-CoR) complex (N-CoR/mSin3A/HDAC)
by forming PML/RARA-CoR or RARA-CoR complexes.
Unlike the RARA-CoR complex, the PML/RARA-CoR com-
plex is more stable and resistant to physiological ATRA treatment.
PML/RARA competes with RARA for binding to the retinoic acid
response elements (RAREs) of target genes and mediating the
transcriptionalrepressionthroughhistonedeacetylationbytheCoR
complex.7-13 Pharmacological doses of ATRA could trigger the
degradation of PML/RARA and the reassembly of PODs.14 More
recently, ATRA has been shown to cause a distinct conformational
change of PML/RARA. This results in release of the CoR complex
and subsequent recruitment of a coactivator (CoA) complex
(CBP/P300, P/CAF, NcoA-1/SRC-1, P/CIP, and ACTR) and con-
verts PML/RARA from transcription repressor to transcription
activator. In contrast, the association of CoR with PLZF/RARA, a
fusion receptor associated with an APL phenotype resistant to
ATRA, could not be modulated by the ligand, even at very high
concentrations.7-13 These ﬁndings further strengthen the concept
that ATRA-induced differentiation is a novel cancer therapy based
on transcriptional regulation.
Although the interaction between ATRA and the aberrant and
wild type RAR-CoR/CoA complexes was largely elucidated, the
molecular events downstream of the RAR complexes were still
unclear. Therefore, using the ATRA-sensitive APL cell line NB4
15
as an in vitro model, we undertook a study based on methods
allowing relatively large-scale transcriptional expression analysis
to identify gene expression patterns in APL cells upon treatment
with ATRA. A total of 169 genes, including transcriptional factors,
signal transduction modulators, cell cycle promoters and inhibitors,
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1496 BLOOD, 15AUGUST 2000z VOLUME 96, NUMBER 4and protein modulators, were conﬁrmed to be ATRA-modulated
and to form a harmonious network in the course of the ATRA-
induced NB4 cell differentiation.
Materials and methods
Cell culture
Retinoid acid (RA)-sensitive NB4 cells were cultured under conditions
previously described.16 The in vitro culture contained 1 mmol/LATRA. For
the cycloheximide inhibition test, NB4 cells were treated with 10 mg/mL
cycloheximide for 30 minutes before ATRA addition and throughout the
ATRAtreatment. Total RNAs were extracted at indicated time-points using
the Trizol reagent (Gibco BRL Life Technologies, Grand Island, NY).
PolyA1 RNAs were puriﬁed using the Oligotex mRNA (messenger RNA)
Kit (Qiagen, Hilden, Germany). Cell differentiation was evaluated for cell
morphology changes using Wright’s staining, CD11b expression, and the
nitroblue tetrazolium (NBT, Sigma Chemical Co, St Louis, MO) reduction
test.17,18 For the detection of cell cycle, the cells were stained with
propidium iodide (PI) (Sigma) and analyzed by a ﬂuorescence-activated
cell sorter (FACS).19 PML/RARA degradation was studied by indirect
immunoﬂuorescence with rabbit antihuman PMLpolyclonal antibodies.14
Differential display-PCR
Differential display (DD)-PCR was performed with the Delta TM Differen-
tial Display Kit (Clontech Laboratories, Palo Alto, CA) following the
instructions of the manufacturer. Reverse transcription reaction was per-
formed with 2 mg total RNA, 1 mLcomplementary DNA(cDNA) synthesis
primer (concentration, 1 mmol/L), and ribonuclease (RNase) free water to a
total volume of 5 mL. After incubation for 3 minutes at 70°C, 2 mL53
ﬁrst-strand buffer, 2 mL dNTP (deoxy nucleoside 59-triphosphate) mix
(total concentration, 5 mmol/L), and 1 mL MMLV-RT (reverse transcrip-
tase) (concentration, 200 U/mL) were added and incubated for 1 hour at
42°C in an air incubator.The reactions were terminated by incubating for 10
minutes at 75°C before storage at 4°C. PCR ampliﬁcation of a given reverse
transcription reaction was carried out in duplicate. A 1-mL RT product was
used for each subsequent PCR in a mixture (total volume, 20 mL)
containing 1 3 KlenTaq PCR reaction buffer, 50 mmol/L dNTP mix, 50
nmol/La–33P-dATP(deoxy adenosine 59-triphosphate), and 0.4 mLAdvan-
tage KlenTaq Polymerase with a different combination of 19 primers. The
following PCR reactions were performed: 1 cycle of 5 minutes each at
94°C, 40°C, and 68°C; 1 cycle of 30 seconds at 94°C, 30 seconds at 40°C,
and 5 minutes at 68°C; 23 cycles of 20 seconds at 94°C, 30 seconds at 60°C,
and 2 minutes at 68°C; and an additional 7-minute cycle at 68°C. The
ampliﬁed cDNAs were separated on 6% polyacrylamide sequencing gels.A
total of 30 differentially expressed bands were obtained and subjected to
further analysis.
Construction of cDNA libraries using suppression-subtractive
hybridization
Suppression-subtractive hybridization (SSH) was performed according to
the user’s manual (Clontech). The FORWARD library for isolating
up-regulated genes was obtained by using cDNA of the NB4 cells treated
with ATRA for 48 hours as a “tester,” while cDNA of untreated NB4 cells
was used as a “driver.” The REVERSE library for identifying down-
regulated genes was constructed by replacing the cDNA of untreated cells
as a “tester,” while cDNAof NB4 cells treated withATRAfor 48 hours was
used as the “driver.”
Differential screening of subtractive library
As indicated by the manufacturer’s protocol, 4 3 96 (384) clones from the
FORWARD subtracted library were dotted in duplicate on nylon mem-
branes and hybridized with a–32P–labeled unsubtracted cDNA probes
(tester and driver) as well as subtracted cDNA probes (FORWARD and
REVERSE) to minimize the false-positive clones before embarking further
conﬁrmation. Genes showing equal hybridization signals were ruled out,
while genes with different signals or without any signal were further
investigated.
cDNA array
Membranes with 588 known genes (Clontech) were used, and hybridization
was performed according to the manufacturer’s recommendations using the
RNAfrom 3 independent sets ofATRA-stimulated NB4 cells at an indicated
time-point. The signals were analyzed on Altasvision software (Clontech)
and normalized by the signal intensities of housekeeping genes. Only those
genes with signal differences of more than 2-fold were considered
as modulated.
Sequencing and bioinformatics analysis
Sequencing reactions were performed on a 9600 Thermal Cycler using the
Dye Primer and Dye Terminator Cycle Sequencing Kit (Perkin-Elmer,
Foster City, CA).All sequences were searched against GenBank and dbEST
databases (version 108) for homology comparison by using the Genetics
Computer Group (GCG) program package. The sequences were considered
as part of the known genes if they shared 95% or more homology over at
least a 100-bp (base pair) DNA sequence on the BLAST search. For those
sequences representing previously unknown genes, GenBank and
SWISSPROT searches were performed by using BLAST and FASTA. For
those ESTs without signiﬁcant homology, the motif search was carried out
using the Blocks database, version 9.0 (http://www.blocks.fhcrc.org).
Northern blot analysis, semiquantitative RT-PCR, and real-time
quantitative RT-PCR
Northern blot analysis was performed as previously described.20 For
semiquantitative RT-PCR, G3PDH was used as an internal control with the
following primer sets: sense, 59-TGA AGG TCG GAG TCA ACG GAT
TTG GT-39, and antisense, 59-CAT GTG GGC CAT GAG GTC CAC
CAC-39. G3PDH and gene-speciﬁc primers were placed in a single tube.
PCR was performed in 20-mL volumes using the Perkin-Elmer Cycler 480
(Perkin-Elmer) at the following conditions: 1 cycle for 5 minutes at 94°C;
20-30 cycles for 45 seconds at 94°C, 45 seconds at 56°C, and 1.5-2 minutes
at 72°C. All RT-PCR reactions were repeated at least 3 times at different
numbers of the extension cycle to avoid the false results of the PCR. The
signals were normalized against 983-bp G3PDH using a densitometer.
Triplicate real-time RT-PCR was performed using the ABI PRISM 7700
Sequence Detection System (Perkin-Elmer) with the same RNA templates
of semiquantitative RT-PCR. b-Actin was coampliﬁed as an endogenous
control to standardize the amount of the sample RNAadded to the reaction.
The results of the indicated time-points after the ATRA treatments were
plotted relative to the level at time zero.
Full-length cDNA cloning and sequencing
Two methods were used for full-length cDNA cloning: “in silico” cloning
and the rapid ampliﬁcation of the cDNAend (RACE). The in silico cloning
started from novel cDNA sequences obtained in the current work, and
overlapping dbEST sequences were assembled into contigs to get the open
readingframes(ORFs),whichweresubjecttofurthercheckbyRT-PCRand
subsequent sequencing. In RACE, self-made marathon-ready cDNAs were
used as templates, and the touchdown PCR reaction was carried out
according to the manufacturer’s protocol. Candidate bands were cut and
cloned into pGEM-T (Promega Company, Madison, WI) or pT-Adv vector
(Clontech). The sequences were analyzed for possible ORFs using the
Autoassembler and Strider 1.2 program. If necessary, further RACE
walking was performed until a complete ORF was obtained.
Results
Identiﬁcation of the genes modulated by ATRA in NB4 cells
Using 3 techniques, a number of genes and cDNA clones were
identiﬁed as being regulated in NB4 cells after treatment with
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analysis revealed a total of 99 of 588 (16.8%) “hot spot” known
genes to be modulated with more than a 2-fold difference of
expression levels between ATRA-treated NB4 cells and un-
treated cells (Figure 1A). Among these 99 genes, 37 presented
up-regulated signals, and 62 were down-regulated. The expres-
sion of 8 up-regulated genes and 2 down-regulated genes was
conﬁrmed by RT-PCR with coherent patterns (data not show).
Using DD-PCR, 13 of 30 bands were identiﬁed and subse-
quently conﬁrmed to represent genes with induced expression,
while probes prepared from 7 of 30 bands gave signals of equal
intensity before and after ATRA treatment, as detected by
Northern blot analysis. Using Northern blotting, there were no
signals in 10 of 30 bands.
SSH gave rise to a total of 703 clones (660 from FORWARD
and 43 from REVERSE). Sequence analysis of these clones led to
an assembly of 316 contigs (278 from FORWARD and 38 from
REVERSE), of which 159 were known genes; 25 were matched
mitochondria DNA, ribosomal RNA, and Alu repeats; and 132
were novel sequence fragments. The 159 known genes were
subjecttofurtheranalysisusingdifferentialscreeningandsemiquan-
titative RT-PCR. Of these 159 genes, 39.6% were conﬁrmed to be
modulated (55 induced and 8 repressed), whereas the remainder
showed either equal expression patterns or no obvious signals.
Among these regulated genes, 10 were further conﬁrmed by
Northern blotting, which showed a pattern similar to RT-PCR. All
novel sequence fragments were also further examined with differ-
ential screening and RT-PCR, and 49 of 132 showed an ATRA-
modulated expression.
The expression patterns of 3 novel genes were further studied
by real-time quantitative RT-PCR assay, and they turned out to be
highly similar to those from the semiquantitative RT-PCR assay
(Figure 1D). Moreover, 2 methods, in silico cloning (dbEST
version 108.0) and RACE, were carried out to acquire full-length
cDNA from novel gene sequences. The sequences were conﬁrmed
by RT-PCR and/or Northern blot analysis as being modulated by
ATRA. Thus, we obtained 8 cDNA containing putative ORFs
according to bioinformatic analysis. Of the 8 cDNA, 5 showed
signiﬁcant homology to known genes with potential structural
and/or functional importance, whereas 3 exhibited only limited
homology to known genes. Table 1 summarizes the major struc-
tural features of the 8 novel genes in the present work, temporarily
Figure 1. The examples of 4 methods used to conﬁrmATRA-modulated genes in the differentiation of NB4 cells. (A)Apartial view of a cDNAarray result by comparing
the transcriptional expression pattern in untreated NB4 cells (left) with that inATRA-treated NB4 cells (right). The signals of housekeeping genes appeared in the bottom as an
internal control. (B) The results of semiquantitative RT-PCR. The up-regulation of CD52 and the down-regulation of myeloperoxidase seem to be protein synthesis–
independent, while the up-regulation of transglutaminase and myeloid progenitor inhibitory factor was completely suppressed by the protein synthesis inhibitor cycloheximide.
In the ﬁgure, A denotes ATRA; C, cycloheximide; and Ac, a combination of ATRA and cycloheximide. The number denotes hours after treatment. (C) The results of Northern
blotting, with the lower panel showing the loading control (28s rRNA). (D) Relative mRNAlevels of 3 novel genes (RIG-K, RIG-C, and RIG-I) were measured by semiquantitative
RT-PCR and the Taq-man real-time quantitative PCR assay using the same samples. Data from the Taq-man analysis were normalized to mRNAconcentrations according to
the concentration of internal control actin and plotted relative to the level at time zero. The expression proﬁles of these genes, as measured by these 2 independent methods,
were quite similar.
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nucleic acid sequences, as well as deduced amino acid sequences,
are now available in GenBank.
The overall results obtained using these 3 approaches seemed to
be quite cohesive and complimentary. For example, RIG-E, RIG-G,
and dioxin-inducible cytochrome P450 genes initially discovered
by DD-PCR were also found to be up-regulated by SSH, whereas
the induction of 16 genes, such as the monocyte chemoattractant
protein (MCP), interleukin-8 (IL-8), the Src-like adaptor protein,
and Bﬂ-1, were revealed by both cDNA array and SSH. The
advantage of combining the 3 different methods was based on the
concept that each of them might reﬂect a gene expression proﬁle
from a particular angle. The cDNA array used in this work only
covers 588 known genes. DD-PCR generates a partial view of gene
expression, while SSH may allow a more global approach for
identiﬁcation of both known and novel genes, although the
efﬁciency of the method (in this work, 38.5%) needs to be further
improved.After integration of the results by different techniques, a
total of 169 genes were identiﬁed as ATRA-responsive, including
100 up-regulated and 69 down-regulated genes (Figure 2A-J).
Figure 2. Functional classiﬁcation of genes modulated by ATRA during differentiation of NB4 cells. A total of 169 ATRA-modulated genes (100 up-regulated and 69
down-regulated) are clustered into 10 groups (groups A-J) according to their functions. The expression pattern of each gene is displayed here as a horizontal strip, with the
down-regulated genes on the left-hand side of the graph and the up-regulated ones on the right-hand side. For each gene, the ratio of mRNAlevels in NB4 cells at the indicated
time after ATRA treatment to its level in untreated (time zero) NB4 cells is represented by a color, according to the color scale at the bottom. Genes whose expression was
resistant to cycloheximide are highlighted by using the yellow background in the column for gene names. Regarding genes also existing in Golub’s system withAffymetrix chips,
different colors were used to label the column of their accession numbers. The genes with the same expression pattern in both systems are painted in rose; those modulated in
our system but not in Golub’s are painted in sky-blue; while those with opposite patterns are painted in purple.
Table 1. Details of 8 novel ATRA–up-regulated genes
Gene name, perm (temp) Length, bp ORF, bp Peptides, aa Homology Accession No.
hUCE (RIG-A) 1223 48-506 153 mouse UBcM4 AF061736
hLAP (RIG-B) 2147 187-1743 519 leucine amino peptidase AF061738
hWSB-1 (RIG-C) 2048 266-1528 421 mouse WSB-1 AF069313
hPTP (RIG-D) 3610 73-2493 807 mouse hematopoietic cell protein tyrosine phosphatase AF077031
hRD (RIG-H) 1390 8-976 323 rat retinol dehydrogenase type III AF067174
SIH001 (RIG-J) 1613 245-802 186 mouse FMLCl1 (28.7% identities in 115 aa) AF061739
SIH002 (RIG-K) 4347 0-2319 773 human titin (31.2% identities in 415 aa) AF077041
SIH003 (RIG-L) 2107 381-1331 317 human ubiquitin C-terminal hydrolase
(42.1% identities in 133 aa)
AF077040
The major structural features of the 8 novel genes in the present work, including their temporary name of RIG (retinoic acid–induced gene), nucleic acid sequences, open
reading frames (ORFs), and deduced amino acid sequences, are now available in GenBank.
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The 100 up-regulated and 69 down-regulated genes byATRAwere
classiﬁed into 10 categories according to their structures and/or
functions (Figure 2A-J). Some transcription factors, such as c-JUN,
ETR, ID-2, HOX-A1, and CEBPe, were found to be induced.
Interestingly, one component of CoA, ACTR,21 was also included in
this group as a relatively early induced gene (12 hours). Genes
participating in several important signal transduction pathways,
including JAKs/STAT, cAMP/PKA, PKC, and calmodulin, were
modulated. Other notable categories of genes included those
responsible for protein modulation, such as UAE122 and SUMO-
123; for apoptosis resistance, DAD-1,24 Bﬂ-1,25 and GADD15326;
and p19INK4d and p21WAF1/CIP1 for cell cycle exit.27,28 A number of
genes reported to possess the function of proliferation suppression,
including BTG1,29 Src-like adaptor protein,30 FGR,31 and LIMK,32
were also positively modiﬁed. The induced expression of some
neutrophil function-related genes (eg, MCP-1,33 defensin, and
X-CGD) may reﬂect biological activities needed in terminal
granulocytic differentiation.
On the other hand, 69 down-regulated genes could be of
functionalimportanceintermsofcellgrowthregulation.Transcrip-
tion factors known to be capable of promoting cell proliferation,
including c-MYC, NFkB, and GATA2,34 were down-regulated
shortly upon effect of ATRA. A cluster of genes responsible for
DNA synthesis, repair, and recombination were also down-
regulated. With regard to cell cycle checkpoint transition, the
expression of both cyclin A35and B136 was repressed. Of note, 3
families of mitogen-activated protein kinases, namely p38, JNK2,
and ERK3, were all found with decreased levels of expression,
suggesting that the MAPK/SAPK pathways could be transcription-
ally modulated in favor of growth arrest. Some apoptosis agonists,
such as the ICH-1L and FAST kinases, showed decreased levels of
expression.Inaddition,myeloperoxidase,thecytoenzymaticmarker
ofAPLcells, was also down-regulated. It may be interesting to note
that the expression of transcription factor AP-1 was biphasic
because c-FOS was suppressed within 8 hours. This was followed
by an increased expression at 24 hours, which coincided with the
induction of c-Jun after 24 hours ofATRAtreatment.
Identiﬁcation of possible direct target genes of ATRA
We tried to ﬁnd the genes whose transcriptional regulation was
protein synthesis–independent and thus most likely represented
target genes of RA receptors. By using the cycloheximide inhibi-
tion test, the response of 8 up-regulated genes to ATRA was not
abolished by protein synthesis antagonist.That all these genes were
up-regulated at an early stage (within 12 hours) was also in support
of their direct induction by RAreceptors.Among these 8 cyclohex-
imide-resistant up-regulated genes, one of them is CEBPe, which
has been conﬁrmed by other groups to be very important for the
initiation of granulocytic differentiation.37-39 Cell cycle inhibitor
p21WAF1/CIP1, apoptosis antagonists Bcl-2–related (Bﬂ-1) and
GADD153 (CHOP), and some receptors and membrane proteins
Figure 2 (Cont’d)
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group. Surprisingly, the transcriptional modulation in 24 of 69
down-regulated genes appeared not to be inhibited by cyclohexi-
mide, and the onset of their down-regulation all occurred within 8
hours after treatment withATRA(Figure 2A-J).
Gene expression waves in concert with APL cell differentiation
To receive insight into the gene expression network modulated by
ATRA, it is important not only to obtain the gene catalog in the
network but also to clarify the time course of the transcriptional
regulation in each of the modulated genes. To this end, a better
deﬁnition of the phenotypic changes of NB4 cells uponATRA, with
regard to time course, was necessary. At the early time-points (8
and 12 hours) of the ATRA treatment, there were no obvious
morphological changes in the NB4 cells (Figure 3). The percent-
ages of CD11b1 cells were still at the same level as that of time
zero. PML/RARA degradation was not yet distinct. However, the
increase of the G0/G1-phase cells and decrease of the S-phase cells
were concomitant with the depression of cell proliferation that was
started prior to 8 hours ofATRAtreatment.After 24 hours ofATRA
treatment, the differentiation markers of the NB4 cells began to be
observable. CD11b1 and NBT1 cells gradually increased from
24-72 hours after treatment. The ratio of cytoplasm to nucleus was
increased, and the chromatin condensation occurred gradually.
There was no evident apoptosis observed during the whole course
of the treatment. Meanwhile, PML/RARA degradation could be
readily observed. Therefore, the time course of differentiation
could be roughly divided into 2 phases: before 12 hours and after
12 hours of treatment.
In agreement with the above observation, the expression
patterns of the 169 genes were studied using the cDNA array,
semiquantitative RT-PCR, and/or Northern blot analysis on NB4
cells prior to ATRA treatment and at 8, 12, 24, 48, and 72 hours
after treatment (Figure 1B,C). (For some genes, Northern blot
analysis was performed as early as 4 hours.) Among the 100 genes
with up-regulated expression, 53 genes (53%) were induced within
12 hours, 46 genes (46%) were induced between 24 and 48 hours,
and only 1 gene was induced after 72 hours. In contrast, the
modulation patterns of the 69 down-regulated genes were quite
different because the expression level in 59 genes rapidly declined
8 hours after ATRA treatment, and the expression was suppressed
in only 10 genes after 12 hours. Of note, 9 genes suppressed early
by ATRA treatment showed increased expression or were restored
to basal expression at a late stage (Figure 2A-J).
The time course of the regulated gene expression patterns was
highly associated with the differentiation status of NB4 cells. Genes
modulated before 12 hours (such as CEBPe and p21WAF/CIP) were
thought to be more important for the initiation of differentiation.
Those with modulated expression after 12 hours (such as ICAM1
and neutrophil cytosol factor–1) might be more tightly associated
with the progression of differentiation and/or functional adjustment
of the maturing cells. The modulation of cell cycle regulators (the
up-regulation of p21WAF/CIP and the down-regulation of cyclin A,
cyclin B, etc), DNA synthesis and/or repair, and recombination
proteins (eg, double-stranded RNA binding proteins, ERCC3 and
XRCC1) at quite an early time course of ATRA treatment
corresponded to the cell cycle arrest and proliferation inhibition.
Most of the protein modulators were up-regulated after 12 hours of
ATRA treatment, and this was highly related to the degradation of
PML/RARA and the restoration of PODs. The apoptosis-related
genes were regulated at an early stage (8 hours) and lasted up to 72
Figure 3. Differentiation status, cell cycle distribution, and PML-staining patterns of NB4 cells at distinct time-points of anATRAtreatment. Differentiation of the cells
was evaluated by (A) morphological changes (Wright’s staining) and (B) CD11b expression. (C) The percentages of G1/G2- and S-phase cells at the same time-points were
measured by PI staining and FACS analysis. (D) PML/RAR, PML localization in corresponding time-points was studied using immunoﬂuorescence methods with antihuman
PML antibodies.
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regulation of apoptosis antagonists during the whole course of
ATRA treatment could ensure that the cells survive and differenti-
ate terminally.
Discussion
During the last few years, we and several other groups have
isolated, in a piecemeal way, RA-regulated genes during ATRA-
triggered granulocytic differentiation.1 However, there was no
systematic survey of gene expression regulation upon the effect of
ATRA, and few genes were known to be direct targets of RA in
APL cells. Only recently have innovative tools, such as cDNA
microarray, allowed a more global approach of the analysis of
transcriptional regulation including regulation inAPLcells.40 In the
present work, which applied several new techniques, 100 genes,
including 8 novel ones, were found to be up-regulated by ATRA,
while 69 genes were down-regulated. A total of 169 genes were
regulated by ATRA, and they may represent approximately 0.8%-
1.7% of all genes expressed in APL cells (if the estimation that
about 10 000-20 000 genes are expressed in a given cell type
holds).41 There are some overlaps between our results and those of
Tamayo et al,40 whose group used Affymetrix chips to proﬁle the
transcriptional response of NB4 cells toATRA.
A total of 48 up-regulated and 39 down-regulated genes in our
system were also included in the system described byTamayo et al.40 In
addition, 42 of 48 up-regulated genes and 20 of 39 down-regulated
genes were found to have similar expression patterns in both systems,
whichsuggestsarelativelygoodoverallagreement(73.6%)betweenthe
resultsofthese2groupswithdifferenttechnicalapproaches.However,4
of 48 up-regulated genes and 15 of 39 down-regulated genes picked up
in our system were not found to be modulated in the system of Tamayo
et al. Moreover, the modulation patterns of 6 genes were contradictory
between the 2 systems. It is worth pointing out that for the 2
up-regulated genes with a discrepancy (CD11A and LIMK1), our results
of cDNA array were conﬁrmed by RT-PCR. There could be several
reasons to explain these differences. Because all genes with disparate
results were those with only 2-fold to 5-fold modulation, we deduce that
the difference could be caused by distinct sensitivities of the analysis
systems employed. Another possibility is that NB4 cells in different
laboratories could be subject to slightly distinct culture conditions,
which could affect expression of some of the genes.
When RA-modulated genes were analyzed for their func-
tions, a picture of well-coordinated choreography emerged, and
this may reﬂect an elegant and intricate cellular program for the
commitment to differentiation. For example, many studies
suggested that the initiation of differentiation required the
transcriptional activation of speciﬁc genes leading to prolifera-
tion arrest and cell cycle exit. Supporting this notion, indeed, a
number of genes known to be able to suppress proliferation and
cell cycle progress, such as p21WAF1/CIP1, p19INK4D, GADD153,
BTG1, and the Src-like adaptor protein, were up-regulated.
Along these same lines, genes favoring DNA synthesis and/or
repair and G1-S/G2-M transition, such as c-MYC, c-MYB,
GATA2, XRCC1, P55CDC, cyclin A, and cyclin B1, were
down-regulated early during ATRA treatment. Another example
could be the balance between apoptosis and differentiation. It
can be postulated that the apoptosis process, which was favored
by the degradation of PML/RARA and the release of PMLs,5,42
should be temporarily inhibited in NB4 cells until the terminal
differentiation occurs. Of note, several apoptosis antagonists,
such as Bcl-2–related (A1) and DAD1, were up-regulated.
Moreover, FGR protein-tyrosine kinase, which had been demon-
strated to promote RA-induced granulocytic differentiation of
HL-60 cells by preventing programmed cell death, had also been
induced.31 Hence, modulated expression of these genes seems to
offer a survival signal as an essential prerequisite for the cell
maturation process (Figure 4). It is a well-established fact that a
few transcription factors play important roles in RA signal
pathways. The over-expression of these genes could lead cells
into differentiation. It is interesting to detect the up-regulation
of one of them, namely CEBPe, which is reported to be
extremely important for myeloid cell differentiation. Its induced
expression is always accompanied by granulocytic differentia-
tion; its over-expression could lead U937 cells to mature
granulocytes; and its induction is in a ligand-dependent manner
by PML/RARA but not by PLZF/RARA.37-39
A previous study23 indicated that POD reorganization repre-
sented an immediate consequence of PML/RARA degradation,
which could be inhibited by lactacystin, a speciﬁc inhibitor of
proteasome.14 To this end, it is worth noting that 2 enzymes
implicated in the step-wise catalysis of binding the ubiquitin
polymer to the target protein, the ubiquitin-activating enzyme E1
(UAEE1) and ubiquitin-conjugating enzyme (UCE) genes,22 were
up-regulated at 8 hours and 24 hours, respectively, after ATRA
treatment. SUMO-1, which encodes a ubiquitin-like protein report-
edly to be involved in PML relocalization,23 was induced after 4
hours of ATRA treatment. Interestingly, 2 novel genes isolated in
the present work, RIG-A and RIG-B, share, respectively, 55% and
92% amino acid identities with the mouse ubiquitin-conjugating
enzyme and cattle leucine aminopeptidase. This suggests that they
may also be implicated in the regulation of protein modiﬁcation.
To distinguish genes as the direct targets of ATRA and as those
regulated by the protein products of the direct targets will lead to
the dissection of different gene expression “waves” during cell
differentiation. The cycloheximide inhibition test suggested that
8 up-regulated genes could be direct targets of RA receptors
(Figure 2). The presence of RARE at the promoter regions in 3
up-regulated genes with available 59-ﬂanking sequences, namely
RIG-E (M.M. and Z.C., unpublished data, August 1998), ICAM-
1,43 and p21WAF1/CIP1,44 is in agreement with the current model of
ligand-dependent control of the RA receptor activity. In various
Figure 4. The putative mechanism of cell cycle exit in APL cells upon the effect
ofATRA. p21WAF1/CIP1 may function at the upstream differentiation program initiation.
Members of the CEBP family, such as CEBP-e and GADD153 (CHOP), may stabilize
the p21WAF1/CIP1 protein from degradation in the current context. The additional
member of this family, CEBP-a, has been reported to be implicated in the
differentiation of preadipocytes through posttranscriptional stabilization of the
p21WAF1/CIP1 protein (left). Additionally, activation of the cell cycle exit and apoptosis-
resistant pathways appears to be the prerequisite for the initiation of the differentia-
tion program.
1502 LIU et al BLOOD, 15AUGUST 2000z VOLUME 96, NUMBER 4models of differentiation, the induction of p21WAF1/CIP1 appeared to
be essentially required for the G1-S–phase arrest.45,46 One could
therefore image that p21WAF1/CIP1 may act in the upstream of the
differentiation course (Figure 4). The puzzle that 24 genes seem to
be down-regulated with no requirement for protein synthesis
represents a challenge to the current model, which has no explana-
tion for the ligand-dependent transcriptional repression. Several
working hypotheses could, nevertheless, be proposed. First, there
could be a general competition mechanism for the binding of
transcription factors to CoA or CoR molecules.47 Second, the
release of wild type PML and PLZF, which were both found to be
sequestered by PML/RARA, could restore their function as growth
suppressors. Of note, PLZF has been shown to repress the
expression of the cyclin A gene.35 Third, there could be an
opposition between the effects of RA signaling and AP-1.48-50 It is
worth mentioning that the promoter regions of some of the ATRA
down-regulatedgenes,suchasTFandDNA(cytosin-5)-methyltrans-
ferase, containAP-1 sites.51,52
The signiﬁcance of cross-talk or coupling between nuclear and
cytosolic signalings in APL cell differentiation has recently drawn
much attention. In this work, we found that a number of genes
encodingmoleculesinvolvedinimportantcytosolicsignaltransduc-
tion pathways were modulated by ATRA. These include cytosolic
kinase signal transducers such as cytokine receptors STATs/ISGs,
cAMP/PKA, and MAPK/P38/JNK. The functions of the 2 novel
genes, RIG-C and RIG-D, should be further studied because they
share, respectively, 92.6% and 79% amino acid identities with
mouseWSB-1andhematopoieticintracellularproteintyrosinephospha-
tase, both being important regulators in signal transduction.53,54
In conclusion, by applying large-scale screening of the differen-
tially expressed genes during ATRA-induced APL cell differentia-
tion, we identiﬁed 169 modulated genes, which could be divided
into 10 functional groups. A model of gene regulatory network
during this process was thus obtained and provided precious
datasets for further work to ultimately clarify the mechanism of
APLleukemogenesis andATRA-induced differentiation.
Acknowledgments
The authors thank J. Gu for constructive discussion and Q. H.
Huang, J. Zhou, P. M. Jia, Y. P. Yu, and S. H. Xu for excellent
technical assistance.
References
1. Ari M, Jonathan DL. Deconstructing a disease:
RARa, its fusion partners, and their roles in the
pathogenesis of acute promyelocytic. Blood.
1999;93:3167.
2. Dyck JA, Maul GG, Miller WH, Chen JD, Kaki-
zukaA, Evans RD.Anovel macromolecular struc-
ture is a target of the promyelocyte-retinoic acid
receptor oncoprotein. Cell. 1994;76:333.
3. Mu ZM, Chin KV, Liu JH, Lozano G, Chang KS.
PML, a growth suppressor disrupted in acute pro-
myelocytic leukemia. Mol Cell Biol.
1994;14:6858.
4. Wang ZG, Delva L, Gaboli M, et al. Role of PML
in cell growth and the retinoic acid pathway. Sci-
ence. 1998;279:1547.
5. Wang ZG, Ruggero D, Ronchetti S, et al. PML is
essential for multiple apoptotic pathways. Nat
Genet. 1998;20:266.
6. Kastner P, PerezA, Lutz Y, et al. Structure, local-
isation and transcriptional properties of two
classes of retinoic acid receptor a fusion proteins
in acute promyelocytic leukemia (APL): structural
similarities with a new family of oncoproteins.
EMBO J. 1992;11:629.
7. Hong SH, David G, Wong CW, DejeanA, Prival-
sky ML. SMRT corepressor interacts with PLZF
and with the PML-retinoic acid receptor a (RARa)
and PLZF-RARa oncoproteins associated with
acute promyelocytic leukemia. Proc NatlAcad Sci
U SA. 1997;94:9028.
8. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr,
Evans RM. Role of the histone deacetylase com-
plex in acute promyelocytic leukemia. Nature.
1998;391:811.
9. Grignani F, De Matteis S, Nervi C, et al. Fusion
proteins of the retinoic acid receptor-a recruit his-
tone deacetylase in promyelocytic leukemia. Na-
ture. 1998;391:315.
10. Collins SJ.Acute promyelocytic leukemia: reliev-
ing repression induces remission. Blood. 1998;
91:2631.
11. Guidez F, Ivins S, Zhu J, Soderstrom M, Waxman
S, ZelentA. Reduced retinoic acid-sensitivities of
nuclear receptor corepressor binding to PML and
RARa underlie molecular pathogenesis and treat-
ment of acute promyelocytic leukemia. Blood.
1998;91:2634.
12. He LZ, Guidez F, Tribioli C, et al. Distinct interac-
tion of PML-RARa and PLZF-RARa with co-re-
pressors determine differential responses to RA
inAPL. Nature Genetics. 1998;18:125.
13. Cheng GX, Zhu XH, Men XQ, et al. Distinct leu-
kemia phenotypes in transgenic mice and differ-
ent corepressor interactions generated by promy-
elocytic leukemia variant fusion genes PLZF-
RARa and NPM-RARa. Proc NatlAcad Sci
U SA. 1999;96:6318.
14. Yoshida H, Kitamura K, Tanaka K, et al.Acceler-
ated degradation of PML-retinoic acid receptor a
(PML-RARA) oncoprotein by all-trans-retinoic
acid in acute promyelocytic leukemia: possible
role of the proteasome pathway. Cancer Res.
1996;56:2945.
15. Lanotte M, Martin-Thouvenin V, Najman S,
Balerini P, Valensi F, Berger R. NB4, a maturation
inducible cell line with t(15;17) marker isolated
from a human acute promyelocytic leukemia
(M3). Blood. 1991;77:1080.
16. Duprez E, Ruchaud S, Houge GA, et al.Aretinoid
acid ’resistant’ t(15;17) acute promyelocytic leu-
kemia cell line: isolation, morphological, immuno-
logical, and molecular features. Leukemia. 1992;
6:1281.
17. Makishima M, Honma Y. Ethacrynic acid and 1a,
25-dihydroxyvitamin D3 cooperatively inhibit pro-
liferation and induce differentiation of human my-
eloid leukemia cells. Leuk Res. 1996;20:781.
18. Takuma T, Takeda K, Konno K. Synergism of tu-
mor necrosis factor and interferon-g in induction
of differentiation of human myeloblastic leukemic
ML-1 cells. Biochem Biophys Res Commun.
1987;145:514.
19. Kanatani Y, Kasukabe T, Okabe-Kado J, et al.
Transforming growth factor b and dexametha-
sone cooperatively enhance c-jun gene expres-
sion and inhibit the growth of human monocytoid
leukemia cells. Cell Growth Differ. 1996;7:187.
20. Mao M, Yu M, Tong JH, et al. RIG-E, a human
homolog of the murine Ly-6 family, is induced by
retinoic acid during the differentiation of acute
promyelocytic leukemia. Proc NatlAcad Sci
U SA. 1996;93:5910.
21. Chen H, Lin RJ, Schiltz RL, et al. Nuclear recep-
tor coactivatorACTR is a novel histone acetyl-
transferase and forms a multimeric activation
complex with P/CAF and CBP/p300. Cell. 1997;
90:569.
22. Mark H. Ubiquitin, proteasomes, and the regula-
tion of intracellular protein degradation. Curr Opin
Cell Biol. 1995;7:215.
23. Mu ¨ller S, Matunis MJ, DejeanA. Conjugating with
the ubiquitin-related modiﬁer SUMO-1 regulates
the partitioning of PML within the nucleus. EMBO
J. 1998;17:61.
24. SugimotoA, Hozak RR, Nakashima T, Nishimoto
T, Rothman JH. Dad-1, an endogenous pro-
grammed cell death suppressor in Caenorhabdi-
tis elegans and vertebrates. EMBO J. 1995;14:
4434.
25. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas
C. The prosurvival bcl-2 homolog bﬂ-1/A1 is a
direct transcriptional target of NF-kappa B that
blocks TNFalpha-induced apoptosis. Genes Dev.
1999;13:382.
26. Eymin B, Dubrez L,Allouche M, Solary E. In-
creased GADD153 messenger RNAlevel is asso-
ciated with apoptosis in human leukemic cells
treated with etoposide. Cancer Res. 1997;5:686.
27. Luh FY,Archer SJ, Domaille PJ, et al. Structure of
the cyclin-dependent kinase inhibitor p19Ink4d.
Nature. 1997;389:999.
28. Asada M, Yamada T, Ichijo H, et al.Apoptosis in-
hibitory activity of cytoplasmic p21(Cip1/WAF1) in
monocytic differentiation. EMBO J.
1999;18:1223.
29. Rouault JP, Rimonkh R, Tessa C, et al. BTG1, a
member of a new family of antiproliferative
genes. EMBO J. 1992;11:1663.
30. Roche S,Alonso G, KazlauskasA, Dixit VM,
Courtneidge SA, PandeyA. Src-like adaptor pro-
tein (Slap) is a negative regulator of mitogenesis.
Curr Biol. 1998;8:975.
31. Koko K, Kazunari KY, Tadashi Y, Satoshi O ¨ .L y n
and Fgr protein-tyrosine kinases prevent apopto-
sis during retinoic acid-induced granulocytic dif-
ferentiation of HL-60 cells. J Biol Chem. 1996;
271:11557.
32. Higuchi O, Baeg GH,Akiyama T, Mizuno K. Sup-
pression of ﬁbroblast cell growth by overexpres-
sion of LIM-kinase 1. FEBS Lett. 1996;396:81.
33. Burn TC, Petrovick MS, Hohans S, Rollins BJ,
Tenen DG. Monocyte chemo-attractant protein-1
gene is expressed in activated neutrophils and
retinoic acid-induced human myeloid cell lines.
Blood. 1994;84:2776.
GENE EXPRESSION UNDERLYINGAPLCELLDIFFERENTIATION 1503 BLOOD, 15AUGUST 2000z VOLUME 96, NUMBER 434. Tsai FY, Orkin SH. Transcription factor GATA-2 is
required for proliferation/survival of early hemato-
poietic cells and mast cell formation, but not for
erythroid and myeloid terminal differentiation.
Blood. 1997;89:3636.
35. Yeyati PL, Shaknovich R, Boterashvili S, et al.
Leukemia translocation protein PLZF inhibits cell
growth and expression of cyclinA. Oncogene.
1999;18:925.
36. Innocente SA,Abrahamson JL, Cogswell JP, Lee
JM. P53 regulates a G2 checkpoint through cyclin
B1. Proc NatlAcad Sci U SA. 1999;96:2147.
37. Morosetti R.Anovel, myeloid transcription factor,
C/EBP epsilon, is upregulated during granulo-
cytic, but not monocytic, differentiation. Blood.
1997;90:2591.
38. Lekstrom-Himes JA, Dorman SE, Kopar P, Hol-
land SM, Gallin J. Neutrophil-speciﬁc granule de-
ﬁciency results from a novel mutation with loss of
function of the transcription factor CCAAT/en-
hancer binding protein epsilon. J Exp Med. 1999;
189:1847.
39. Park DJ, ChumakovAM, Vuong PT, et al. CCAAT/
enhancer binding protein epsilon is a potential
retinoid target gene in acute promyelocytic leuke-
mia treatment. J Clin Invest. 1999;103:1399.
40. Tamayo P, Slonim D, Mesirov J, et al. Interpreting
patterns of gene expression with self-organizing
maps: methods and application to hematopoietic
differentiation. Proc NatlAcad Sci U SA. 1999;
96:2907.
41. Alberts B, Bray D, Lewis J, Raff M, Roberts K,
Watson JD. Molecular Biology of the Cell. New
York: Garland Publishing, Inc; 1994:368.
42. Nason-Burchenal K, Takle G, Pace U, et al. Tar-
geting the PML/RARa translocation product trig-
gers apoptosis in promyelocytic leukemia cells.
Oncogene. 1998;17:1759.
43. Cilenti L, Toniato E, Ruggiero P, et al. Transcrip-
tional modulation of the human intercellular adhe-
sion molecule gene I (ICAM-1) by retinoic acid in
melanoma cells. Exp Cell Res. 1995;218:263.
44. Liu M, IavaroneA, Freedman LP. Transcriptional
activation of the human P21WAF1/CIP1 gene by reti-
noic acid receptor: correlation with retinoid induc-
tion of U937 cell differentiation. J Biol Chem.
1996;271:31723.
45. Kenneth W, Harris P. Cell cycle exit upon myo-
genic differentiation. Curr Opin Genet Dev. 1997;
7:597.
46. Steinman RA, Huang JP, Yaroslavskiy B, Goff JP,
Ball ED, NguyenA. Regulation of P21(WAF1) ex-
pression during normal myeloid differentiation.
Blood. 1998;91:4531.
47. Korzus E, Torchia J, Rose DW, et al. Transcrip-
tional factor-speciﬁc requirements for coactiva-
tors and their acetyltransferase functions. Sci-
ence. 1998;279:703.
48. Caelles C, Gonzalez-Sancho JM, MunozA.
Nuclear hormone receptor antagonism withAP-1
by inhibition of the JNK pathway. Genes Dev.
1997;11:3351.
49. Vallian S, Ga ¨ken, JA, Gingold EB, Kouzarides T,
Chang KS. Modulation of Fos-mediatedAP-1
transcription by the promyelocytic leukemia pro-
tein. Oncogene. 1998;16:2843.
50. Lee HY, Walsh GL, Dawson MI, Hong WK, Kurie
JM.All-trans retinoic acid inhibits Jun N-terminal
kinase-dependent signaling pathways. J Biol
Chem. 1998;273:7066.
51. Felts SJ, Stoﬂet ES, Eggers CT, Getz MJ. Tissue
factor gene transcription in serum-stimulated ﬁ-
broblasts is mediated by recruitment of c-Fos into
speciﬁcAP-1 DNA-binding complexes. Biochem-
istry. 1995;34:12355.
52. BakinAV, Curran T. Role of DNA5-methylcy-
tosine transferase in cell transformation by fos.
Science. 1999;283:387.
53. Matthews RJ, Bowne DB, Flores E, Thomas ML.
Characterization of hematopoietic intracellular
protein tyrosine phosphatases: description of a
phosphatase containing an SH2 domain and an-
other enriched in proline-, glutamic acid-, serine-,
and threonine-rich sequences. Mol Cell Biol.
1992;12:2396.
54. Hilton DJ, Richardson RT,Alexander WS, et al.
Twenty proteins containing a C-terminal SOCS
box form ﬁve structural classes. Proc NatlAcad
Sci U SA. 1998;95:114.
1504 LIU et al BLOOD, 15AUGUST 2000z VOLUME 96, NUMBER 4